Quote from riskarb:
Mav, that's not a large short position in biotech. I can't imagine too many shorts going into the number short with a large position, hence the run in the shares in recent weeks/months. For sure it pops 20% on the approval though.
riskarb
10% is not exceptionaly high for any stock, let alone a BIO.
Most definately not large enough to warrant a "massive squeeze". Arb gl with your play, something tells me after seeing the company you have with you -- ur gonna need it.
Die,
JC

